Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 85% ± 15% | |
oligodendrocyte precursor cell | 11 studies | 36% ± 17% | |
GABAergic neuron | 10 studies | 83% ± 20% | |
amacrine cell | 7 studies | 50% ± 22% | |
retinal ganglion cell | 7 studies | 63% ± 24% | |
neuron | 6 studies | 55% ± 25% | |
interneuron | 6 studies | 87% ± 11% | |
retina horizontal cell | 6 studies | 57% ± 21% | |
endothelial cell | 4 studies | 46% ± 24% | |
granule cell | 4 studies | 71% ± 12% | |
microglial cell | 4 studies | 35% ± 18% | |
ON-bipolar cell | 4 studies | 35% ± 16% | |
GABAergic interneuron | 3 studies | 89% ± 6% | |
GABAergic amacrine cell | 3 studies | 77% ± 9% | |
glycinergic amacrine cell | 3 studies | 69% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 52% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 4942.18 | 2421 / 2642 | 50% | 2.66 | 354 / 705 |
adrenal gland | 7% | 54.17 | 17 / 258 | 62% | 2.41 | 143 / 230 |
pancreas | 0% | 1.92 | 1 / 328 | 3% | 0.10 | 6 / 178 |
skin | 0% | 0.59 | 2 / 1809 | 3% | 0.07 | 13 / 472 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.03 | 4 / 286 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.04 | 5 / 504 |
liver | 0% | 0 | 0 / 226 | 1% | 0.02 | 4 / 406 |
uterus | 0% | 0 | 0 / 170 | 1% | 0.02 | 4 / 459 |
breast | 0% | 0 | 0 / 459 | 1% | 0.02 | 8 / 1118 |
lung | 0% | 0 | 0 / 578 | 1% | 0.01 | 6 / 1155 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.01 | 2 / 527 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.01 | 1 / 430 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.00 | 1 / 605 |
muscle | 0% | 0.52 | 1 / 803 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 1 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
esophagus | 0% | 0 | 0 / 1445 | 0% | 0 | 0 / 183 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030182 | Biological process | neuron differentiation |
GO_0048665 | Biological process | neuron fate specification |
GO_0007399 | Biological process | nervous system development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0048666 | Biological process | neuron development |
GO_0048663 | Biological process | neuron fate commitment |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | MYT1L |
Protein name | MYT1L protein (Myelin transcription factor 1 like) Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) Myelin transcription factor 1 like |
Synonyms | KIAA1106 |
Description | FUNCTION: Transcription factor that plays a key role in neuronal differentiation by specifically repressing expression of non-neuronal genes during neuron differentiation. In contrast to other transcription repressors that inhibit specific lineages, mediates repression of multiple differentiation programs. Also represses expression of negative regulators of neurogenesis, such as members of the Notch signaling pathway, including HES1. The combination of three transcription factors, ASCL1, POU3F2/BRN2 and MYT1L, is sufficient to reprogram fibroblasts and other somatic cells into induced neuronal (iN) cells in vitro. Directly binds the 5'-AAGTT-3' core motif present on the promoter of target genes and represses transcription by recruiting a multiprotein complex containing SIN3B. The 5'-AAGTT-3' core motif is absent from the promoter of neural genes. . |
Accessions | ENST00000648933.1 A0A3B3IS61 A0A2R8YF72 A0A3B3IUE2 ENST00000648366.1 A0A3B3IRK4 ENST00000648316.1 [Q9UL68-4] ENST00000485348.3 ENST00000649663.1 A0A3B3ISN1 A0A3B3IRQ0 ENST00000647755.1 A0A3B3ITJ8 ENST00000407844.6 [Q9UL68-3] ENST00000648928.1 [Q9UL68-4] ENST00000470954.3 A0A3B3IS77 H7BYU4 A0A3B3IS97 ENST00000649840.2 ENST00000399161.8 [Q9UL68-4] ENST00000648885.2 A0A3B3ISG9 ENST00000649810.1 ENST00000490585.2 A0A8I5KQG8 ENST00000647738.2 [Q9UL68-1] A0A3B3IRX0 ENST00000649207.1 [Q9UL68-4] A0A3B3IRM3 A0A3B3ISW5 ENST00000648931.2 A0A3B3IRR4 ENST00000399157.8 A0A3B3IRT9 ENST00000649709.2 Q9UL68 A0A3B3IS14 ENST00000647618.1 A0A3B3IT20 A0A3B3IU66 A0A3B3IRX5 A0A3B3ISU4 ENST00000689939.1 ENST00000648339.1 ENST00000471668.1 ENST00000650399.2 ENST00000648753.2 A0A3B3ISB6 ENST00000650485.2 A0A3B3IRF0 ENST00000649587.1 A0A3B3ISU9 ENST00000649092.2 A0A3B3ITL3 ENST00000648943.2 A0A3B3ITS6 ENST00000648627.1 A0A3B3IU83 ENST00000647694.1 [Q9UL68-1] ENST00000650560.1 A0A3B3ISP2 A0A3B3IS21 A0A3B3IRJ2 A0A3B3ISN3 ENST00000647848.1 ENST00000648430.2 A0A3B3ISI4 ENST00000649313.2 ENST00000602387.6 ENST00000647687.2 ENST00000650081.1 Q49A74 A0A3B3ITT2 ENST00000648665.2 R4GMY9 ENST00000644820.1 ENST00000649741.2 ENST00000650589.2 ENST00000649641.2 ENST00000428368.7 [Q9UL68-1] ENST00000648318.1 |